OrbiMed
Founded:
1989
Investments:
562
Exits:
212
OrbiMed is a healthcare-dedicated investment firm focusing on biopharmaceuticals to medical devices and diagnostics.
Portfolio companies:
Aspen Neuroscience,Carrot Fertility,Sionna Therapeutics,GentiBio,XtalPi,ReCode Therapeutics,Scribe Therapeutics,Entos,Q32 Bio,ACELYRIN,Cyrus Biotechnology,iECURE,Gennao Bio,Enliven Therapeutics,ArriVent Biopharma,Crown Bioscience,Pionyr Immunotherapeutics,Odyssey Therapeutics,Adicet Bio,Binx Health,Turnstone Biologics,Electra Therapeutics
BioTech
HR Tech
FemTech
Health & Wellness
Artificial Intelligence & Machine Learning (AI/ML)
Software
New York
Seed
Series A
Series B
Series C
Series D
United States